The glycoproteins of filamentous fungi have attracted increasing interest over the last few years. Fungi have been used in the commercial production of several enzymes of industrial application. Most of these are hydrolases, several of which are glycoproteins.
Several strains of Aspergillus and Trichoderma species, in particular, have been developed that are very efficient secretors of glycoproteins. Yields of over 20 g per litre have been reported. Most hyphal fungi can be grown on relatively simple and cheap media. The fact that some species can utilize waste materials, sometimes solid or semi-solid, may also be seen as environmentally important. More recently these two genera, in particular, have been used for heterologous expression and secretion of glycoproteins of potential industrial and therapeutic use.
Apart from this biotechnological aspect, there is a great deal of medical interest in the allergenic factors (proteins and/or glycoproteins) produced by the few, but important, pathological species of Aspergillus.
Some idea of the range of fungal hydrolases used commercially is gained from Table 1 [l]. These account for a significant part of an estimated Abbreviations used: cbh-I, cellobiohydrolase I; r.e.r.? rough endoplasmic reticulum; DolPMan, dolichyl phosphate mannose.
world market of industrial enzymes in excess of $US. 1500million per annum. The products of Aspergi'llus sp., especially A. nker and A. orzyza have featured prominently in the food industry without health risk, suggesting that fungi such as these should be safe when used for production of heterologous glycoproteins.
At least three of the enzymes of Table 1 have been shown to be glycoproteins. The genes of several others show potential N-glycosylation sites (Asn-Xaa-Thr/Ser) but direct evidence of the presence of glycan is lacking. Some caution is required in interpretation of the presence of these triplets, for several endogenous bacterial enzymes have also been shown to contain them but clearly are not glycosylated.
The biochemistry and molecular genetics of a number of the glycosidases of Table 1 this linker region exists as a semi-flexible rod. It allows movement of the other domains while constraining their relative positions. It has been suggested [6, 7] that the linker glycopeptide may play a role in directing the enzyme towards the cell surface. Other possible consequences are ensuring stoichiometric binding to the starch, the prevention of aggregation, protection from proteolysis and an increase in thermostability. In fact, a relatively low thermostability is one of the industrial disadvantages of this enzyme. Two asparagine residues of glucoamylase are glycosylated, both being in the catalytic domain and both carrying oligomannosyl glycans. The shorter glycan on Asn-171 is close to the putative catalytic site at Glu-179 but appears to have no influence on the enzymic activity. Both N-glycan chains interact with the peptide chain through their terminal mannose residues.
The cellulase complex of Trichoderma reesei has several features analogous to those of the glucosamylase of A. nker. Its component enzymes (cellobiohydrolases-I and -11, B-endoglucosidase) are secreted very efficiently. Yields of over 3Og.l-' of medium have been quoted [8] . Detailed study of cellobiohydrolase-I (cbh-I) has revealed a similar domain structure made up of catalytic-, linker-and cellulose-binding domains [9, lo] Fungal proteases are important to a discussion of fungal-secreted glycoproteins in several respects. Some secreted proteases of industrial use are glycoproteins. On the other hand, some degrade other valuable secreted glycoproteins. Within the mycelium, proteolytic activity is essential to the proper processing of glycoproteins destined for secretion. The presence in Aspergillus and Trichoderma of proteolytic activity, similar to that of the KEX2-endoproteinase of yeast, has been described [ 141. Finally, there is medical interest in the role that secreted proteinases of pathological fungi may play in tissue damage associated with invasion.
One of the most important 'industrial' proteases is the aspartic proteinase of Rhkomucor sp. used in the cheese industry. This enzyme from R. pusillus and R. miehi has a high milk-clotting activity and low general proteolytic activity ([15] and references therein). The ratio of these activities is affected markedly by the extent of glycosylation.
Aikawa's group reports that in the enzyme from a laboratory strain of R. pusillus, Asn-79 and Asn-188 carry Man,GlcNAc, chains with the further putative site at Asn-113 remaining unglycosylated. They have studied the effect of glycosylation on the heterologous expression and secretion of the R. pusillus enzyme in recombinant yeast. The pattern of glycosylation appeared to be similar to that in the original fungus. Site-directed mutagenesis of Asn-79 to Gln-79 or of Asn-188 to Gln-188 reduced glycosylation and secretion and in the double mutant (no N-glycosylation) secretion was only 5% of normal. The enzyme accumulated inside the cell. Replacement of Asn-1 1 3 by Gln-1 13 had no effect. They conclude that glycosylation of both Asn-79 and Asn-188 is required for good secretion. Table 2 (a) summarizes the effects of glycosylation on the clotting and proteolytic activity of these products. The effect of glycosylation of Asn-79 was rationalized on the basis of its location in a 'flexible flap region' crossing the substrate- binding cleft perturbing the flap structure, so influencing enzyme activity. Glycosylation of Asn-188 has been assumed to influence the overall shape of the enzyme.
In a separate study by the same group, investigation of the glycans of Asn-79 and Asn-188 of the R. pusillus enzyme expressed in recombinant yeast or Aspergillus oryza showed them to have increased in size to Man,GlcNAc,. Table 2(b) summarizes the effect of these changes on enzymic activity. It can be seen that the increased glycan size further reduced the ratio of clotting to proteolytic activity. Similar observations of the effect of glycosylation on chymosin activity and secretion have been made [16] in studies on the heterologous expression in A. niger var. awamori and A. oryza of the genes for bovine chymosin or the aspartyl proteinase of Rhizomucor miehei. An N-glycosylation site was engineered into bovine chymosin at a position analogous to Asn-79 of the fungal enzyme with a consequent 3-fold increase in secretion but a 5-fold decrease in clotting activity.
A number of proteases secreted by Aspergillus have been subject to scrutiny recently. These reports show that heterologous proteins are not produced as efficiently as homologous proteins when using strains of high secretory efficiency. It is also clear that heterologous fungal proteins are produced more efficiently ( 10-20% of homologous) than non-fungal proteins ( > 1% of homologous). The challenge to increase yields of heterologous proteins has stimulated interest in selection of appropriate vectors and promoters. The use of the promoters of the highly expressed and inducible glucoamylase gene (glaA) in A. niger and the cbhI gene (cbhl) in T reesei has proved popular. In fact, constructs incorporating the whole genes for these enzymes separated from the heterologous protein by a proteolytic sensitive site (e.g. a KEX2-like site) have resulted in much improved yields. Examples of this approach are the fusion proteins glucoamylase-interleukin-6, in A. nduluns [ 341, glucoamylase-pig prophospholipase A, in A. niger [35] , truncated glucosamylase-chicken lysozyme in A. niger [36] , and cbhI-human Fab in T reesei [8] .
Some secreted proteins are vulnerable to the activity of secreted proteases, which may drastically reduce yields. Selection of mutant strains that secrete very little protease activity [37] or disruption of genes [ 161 for these enzymes has proved beneficial in several studies.
The N-linked and 0-linked mannans of hyphal fungi closely resemble those found in yeast, although hypermannosylation appears to be a rare event. In this regard, A. niger, A. opza and T reesei are better able than yeast to produce the high-mannose N-glycans found in animal cells. Some glycan structures are unique to fungal glycoproteins (see for example those with allergenic activity already described).
It is assumed [25-271 that the basic mechanisms of secretion and protein glycosylation are the same as in other eukaryotic organisms, especially yeast with most exocytosis occurring at the hyphal tip and the cell wall sequestering, in some cases, a large part of the secreted protein. This would involve assembly of N-linked glycans on dolichyl phosphate in the rough endoplasmic reticulum (r.e.r.) prior to transfer to nascent peptide. Dolichyl phosphate mannose (DolPMan) would be expected also to be the donor for 0-mannosylation in the r.e.r. Evidence for the presence of dolichol, the formation of DolPMan and its possible involvement in protein mannosylation was first observed many years ago in my laboratory [38] . Subsequently, DolPMan was shown to be involved in protein 0-mannosylation in A. niger [39] , in Neurospora crassa [40] and in Fusarium solanif: pisi [41] . However, transfer of mannose from GDP-mannose into a 5-0-~-1~-galactofuranosyl-containing extracellular glycopeptide of Penicillium charlesii appeared not to involve DolPMan [42] . There is no published information on the biosynthesis of the galactomannan of A. fumigatus. The inhibitory effect of tunicamycin on the secretion of some glycoproteins [43] In summary, it is clear that it is possible to select strains of hyphal fungi that are very efficient I83 secretors of proteins. Good progress is being made in achieving reasonable yields of heterologous proteins from these strains. Several of the secreted proteins are glycosylated and, if necessary, it is possible to select strains which yield N-linked oligomannosyl glycans very similar to those produced in animal systems. The factors affecting protein glycosylation and its role in secretion require much more study. It is already apparent, however, that glycosylation patterns vary markedly from one species to another and that within one strain the consequences of glycosylation on efficiency of secretion also vary from one glycoprotein to another. Examples of the extent and pattern of glycosylation of a glycoprotein influencing its biological activity and immunological activity are now well documented but this is by no means a general phenomenon. In short, there are few easy generalizations to be made, other than that you cannot afford to ignore the possible consequences of fungal glycosylation and much more work needs to be done in this area. The universal nature of the altered glycosylation and the diverse functions of the affected glycoproteins probably explain the wide involvement of different organs and tissues. There is severe involvement of the nervous system in all patients, such as psychomotor retardation, axial hypotonia, ataxia, hyporeflexia, squint and, in older patients,
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